DUBLIN, March 11, 2021 /CNW/ -- Endo International
plc (NASDAQ: ENDP) ("Endo") today announced that its wholly-owned
subsidiaries Endo Luxembourg Finance Company I S.à r.l. ("Endo
Luxembourg") and Endo U.S. Inc. (together with Endo Luxembourg, the
"Issuers") intend to offer senior secured notes, subject to market
and customary conditions. The notes will be senior secured
obligations of the Issuers and will be guaranteed by Endo and
certain of Endo's subsidiaries and will be secured by first
priority liens on the same collateral that secures Endo's
obligations under its existing senior secured credit facilities and
existing senior secured first lien notes.
Endo intends to use the net proceeds from the proposed offering,
together with the proceeds of a previously announced new senior
secured term loan, to refinance its existing term loan.
The notes and the related guarantees have not been, and will not
be, registered under the Securities Act of 1933, as amended (the
"Securities Act"), or any applicable state or foreign securities
laws, and will be offered only to qualified institutional buyers in
reliance on Rule 144A, and to persons outside the United States in compliance with
Regulation S under the Securities Act. Unless so registered, the
notes and the related guarantees may not be offered or sold in
the United States except pursuant
to an exemption from the registration requirements of the
Securities Act and applicable state securities laws. This press
release will not constitute an offer to sell or a solicitation of
an offer to buy any notes or any other securities.
About Endo International plc
Endo is a specialty pharmaceutical company committed to helping
everyone we serve live their best life through the delivery of
quality, life-enhancing therapies. Our decades of proven success
come from a global team of passionate employees collaborating to
bring the best treatments forward. Together, we boldly transform
insights into treatments benefiting those who need them, when they
need them.
Forward-Looking Statements
This press release contains certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995 and the relevant Canadian securities legislation,
including, but not limited to, Endo's financing plans, including
the Issuers' intention to offer notes and the use of proceeds of
the proposed offering. Statements including words such as
"believes," "expects," "anticipates," "intends," "estimates,"
"plan," "will," "may," "look forward," "intend," "guidance,"
"future" or similar expressions are forward-looking statements.
Because these statements reflect Endo's current views, expectations
and beliefs concerning future events, they involve risks and
uncertainties. Although Endo believes that these forward-looking
statements and information are based upon reasonable assumptions
and expectations, readers should not place undue reliance on them,
or any other forward-looking statements or information in this news
release. Investors should note that many factors, as more fully
described in the documents filed by Endo with the Securities and
Exchange Commission and with securities regulators in Canada on the System for Electronic Document
Analysis and Retrieval, including under the caption "Risk Factors"
in Endo's latest Annual Report on Form 10-K and subsequent Form
10-Q and Form 8-K filings, and as otherwise enumerated herein or
therein, could affect Endo's future results and could cause Endo's
actual results to differ materially and adversely from those
expressed in forward-looking statements contained in this
communication. The forward-looking statements in this press release
are qualified by these risk factors and other factors that Endo is
not currently able to predict. Endo assumes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future developments or otherwise, except as may
be required under applicable securities laws.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/endo-international-plc-announces-proposed-private-offering-of-senior-secured-notes-301245508.html
SOURCE Endo International plc